RxDoctor Payments Data

Karen Lytle-Glover

Obstetrics & Gynecology · Newark, DENPI 1336168459

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.5% of the total across 90 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 19.8% — the pattern of someone who eats at a lot of different presentations.

$1,561in general payments, 2019–2025

Across 90 payments — averaging $17.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$309
  • Daiichi Sankyo Inc.$195
  • Amgen$158
  • Merck$99
  • AMAG Pharmaceuticals, Inc.$86
  • Mylan Pharmaceuticals Inc.$80
  • plus $633 from 16 others

What the payments were for

  • Food & beverage$1,47594%
  • Education$866%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,561 in reported general payments places this provider in the 75th percentile of 139 obstetrics & gynecology providers in Delaware.

See all obstetrics & gynecology providers in Delaware

Other obstetrics & gynecology in Newark

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →